Medicine Is Making
Real Progress

A child with rare genetic disease receives newly approved FDA treatment, offering hope for similar patients.

New diagnostic test helps identify ovarian cancer patients who will benefit most from targeted immunotherapy treatment.

Scientists develop a promising breakthrough drug targeting KRAS mutations in pancreatic cancer, offering hope for patients with this deadly disease.

FDA approval of new HIV treatment provides patients with additional therapeutic options.

FDA approval of once-daily HIV treatment pill offers patients improved convenience and care options.

An investigational pancreatic cancer vaccine demonstrates promising lasting results in early trials, advancing hope for patients with this aggressive disease.

Thailand has developed a homegrown cancer drug breakthrough, advancing treatment options and demonstrating medical innovation.

Dogwood Therapeutics receives FDA approval to advance its SP16 cancer program, moving closer to potential patient treatment.

Penn Medicine and Children's Hospital of Philadelphia won a Breakthrough Prize for developing gene therapy that restores vision in patients with inherited blindness.

Phase III success of azetukalner for focal epilepsy marks a major breakthrough toward regulatory approval for patients with limited options.

UCLA researchers discover method to reverse chronic disease without requiring dietary changes.

Novel approach to pancreatic cancer treatment offers unconventional hope through innovative targeting strategies.

New legislation advances FDA-approved psilocybin treatment option for patients in need.

EU launches support program to accelerate development of innovative medical devices and diagnostics.

Kyrgyzstan's unique heart surgery technique offers patients a new treatment option.

Policy initiative to accelerate psychedelic drug research for mental health treatment.

A South African medical first uses liquid nitrogen breakthrough technology to successfully save a teenager's leg.

Four promising new drugs entering treatment options this spring could significantly transform patient care across multiple conditions.

Executive order expedites FDA review of psychedelics for treating mental health disorders.

An unsolved medical mystery led researchers to a life-saving breakthrough that will help patients.

Executive order accelerates legal access to psychedelics for mental health treatment.

Scientists discover a potential new cancer treatment, offering fresh therapeutic possibilities.

EU advances treatment for irregular heartbeats with an innovative medical breakthrough using advanced imaging techniques.

Scientists successfully shrink CRISPR technology for more precise and effective delivery of gene-editing treatments throughout the body.

PDS Biotech's colorectal cancer treatment shows promising trial results, offering hope for improved patient outcomes.

A promising new inflammatory bowel disease treatment shows encouraging results in early clinical trials.

Building community trust in clinical trials leads to greater participation and more successful research outcomes.

Clinical trials achieve better outcomes when patients actively participate and communicate, improving research quality.

Discovery of a rare genetic mutation leads to HIV cure in a patient, offering hope for future treatments.

UT MD Anderson shares exciting new cancer research breakthroughs at major conference.

A breakthrough transseptal puncture device receives FDA clearance, offering patients a safer alternative for cardiac procedures.

New research identifies potential treatment pathway for rare Rett Syndrome, offering hope where none existed before.

Revolution Medicines' late-stage trial success brings potential breakthrough pancreatic cancer treatment closer to patients.

Groundbreaking porcine kidney transplant trial offers hope for patients awaiting organ transplants.

Multiple new oncology drugs received FDA approval, expanding treatment options for cancer patients.

FDA approves new cancer drug for trials using innovative nonanimal data, marking progress in both treatment and ethical research.

Groundbreaking microRNA research may unlock new treatments for stress-related conditions.

A cancer treatment demonstrates unexpected benefits beyond initial scientific predictions.

Researchers discover a drug that can draw dormant HIV out of immune cells, offering potential for improved treatment strategies.

CorTec's brain-computer interface receives FDA breakthrough designation to help stroke patients regain mobility and independence.

Event encourages rural youth to pursue medical careers and improve healthcare access.

AI breakthroughs by major biotech and tech companies are accelerating drug discovery and surgical innovation, advancing treatment options.

UNC pharmacy researchers are making progress toward breakthrough treatments for pediatric brain cancer.

Researchers have achieved promising results with a potential new treatment for the deadly brain cancer glioblastoma.

A new daily pill shows promise in extending dogs' lifespans, offering hope for pet owners.

CAR T-Cell cancer therapy shows potential to treat autoimmune diseases, opening new therapeutic possibilities.

FDA clears testing of innovative CAR-T therapy for autoimmune diseases, opening new therapeutic possibilities.

Teddy Bear Clinic gives children hands-on medical experience, reducing healthcare anxiety through play.

Educational museum exhibit promotes healthy eating habits and farm-to-table learning for children.

A symposium showcases significant progress in gastrointestinal cancer treatment options and research initiatives.

A medical breakthrough helps a patient make remarkable progress in their Parkinson's disease recovery.

UVA scientists develop AI tools that accelerate the discovery of new drugs, bringing potential treatments to patients faster.

Breakthrough biomarker discovery approach combines genomic and phenotypic evidence to better understand and treat PTSD.

International trial launches to develop better cancer treatments specifically for young people.

A breakthrough treatment offers renewed hope for Parkinson's patients after years of challenging disease progression.

Seven FDA-approved neurological treatments in early 2026 provide neurologists with powerful new therapeutic options.

VAI researchers are making meaningful progress toward treatments and a potential cure for Parkinson's disease.

Synthetic data is accelerating medical discovery while preserving patient privacy and trust.

A new model is improving the efficiency and effectiveness of medical discovery processes.